2090-0007

Journal of Transplantation

Hindawi Limited

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 154 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact154 DOIs
2

Add abstracts to 13 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact13 DOIs
3

Deposit reference lists for 6 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact6 DOIs

DOIs for this ISSN

Showing the top 5 of 309 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cyclosporine: A Review (10.1155/2012/230386)
ORCID
58.11 210
2 Primary Graft Failure after Heart Transplantation (10.1155/2011/175768)
ORCID
50.32 102
3 Ischemia/Reperfusion Injury, Its Mechanisms, and Prevention (10.1155/2012/610370)
Abstract ORCID
50.00 9
4 A Comprehensive Review of Immunosuppression Used for Liver T… (10.1155/2009/701464)
ORCID
49.67 96
5 Inflammatory Signalling Associated with Brain Dead Organ Don… (10.1155/2013/521369)
ORCID
47.85 81
6 Home and Office Blood Pressure Monitoring in Renal Transplan… (10.1155/2012/702316)
Abstract ORCID
47.71 8
7 Identification of Risk Factors for Vascular Thrombosis May R… (10.1155/2012/793461)
ORCID
46.43 71
8 The Role of mTOR Inhibitors in Liver Transplantation: Review… (10.1155/2014/845438)
ORCID
43.90 56
9 The Major Histocompatibility Complex in Transplantation (10.1155/2012/842141)
ORCID
43.70 55
10 Inflammation and Microvasculopathy in Renal Ischemia Reperfu… (10.1155/2012/764154)
ORCID
41.80 46
11 The Factors That May Predict Response to Rituximab Therapy i… (10.1155/2011/374213)
ORCID
40.84 42
12 Role of Mitogen-Activated Protein Kinases in Myocardial Isch… (10.1155/2012/928954)
ORCID
40.58 41
13 Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanop… (10.1155/2012/896141)
ORCID
40.32 40
14 Antibody-Mediated Rejection: Pathogenesis, Prevention, Treat… (10.1155/2012/201754)
ORCID
39.78 38
15 Antibody-Mediated Rejection: An Evolving Entity in Heart Tra… (10.1155/2012/210210)
ORCID
39.21 36
16 Ureteral Stent Placement Increases the Risk for Developing B… (10.1155/2014/459747)
ORCID
38.91 35
17 Brain Natriuretic Peptide Production and Secretion in Inflam… (10.1155/2012/962347)
ORCID
38.29 33
18 Prognostic Factors for Tumor Recurrence after a 12-Year, Sin… (10.1155/2010/904152)
ORCID
37.96 32
19 Advances and Challenges in Islet Transplantation: Islet Proc… (10.1155/2011/979527)
ORCID
37.63 31
20 Isolation of Human Islets for Autologous Islet Transplantati… (10.1155/2012/642787)
ORCID
37.63 31
21 Prospective Changes in Health-Related Quality of Life and Em… (10.1155/2011/671571)
ORCID
37.28 30
22 Inflammation-Mediated Regulation of MicroRNA Expression in T… (10.1155/2012/723614)
ORCID
36.18 27
23 A Randomized Multicenter Study Comparing a Tacrolimus-Based… (10.1155/2012/894215)
ORCID
36.18 27
24 Everolimus in Heart Transplantation: An Update (10.1155/2013/683964)
ORCID
36.18 27
25 Initial Experience with Sildenafil, Bosentan, and Nitric Oxi… (10.1155/2010/656984)
ORCID
35.78 26
26 Donor Complications Following Laparoscopic Compared to Hand-… (10.1155/2010/825689)
ORCID
35.78 26
27 Donors and Recipients of Living Kidney Donation: A Qualitati… (10.1155/2011/626501)
ORCID
35.78 26
28 Alendronate as an Effective Treatment for Bone Loss and Vasc… (10.1155/2014/269613)
ORCID
35.78 26
29 Use of Adjuvant Sorafenib in Liver Transplant Recipients wit… (10.1155/2014/913634)
ORCID
35.78 26
30 Potential of Dried Blood Self-Sampling for Cyclosporine<mml:… (10.1155/2010/201918)
ORCID
35.37 25
31 A Knotless Technique for Kidney Transplantation in the Mouse (10.1155/2012/127215)
ORCID
35.37 25
32 Outcome and Prognostic Indicators of Patients with Hematopoi… (10.1155/2009/917294)
ORCID
34.51 23
33 Intraoperative Hyperglycemia Augments Ischemia Reperfusion I… (10.1155/2011/652458)
ORCID
34.51 23
34 BK Virus in Kidney Transplant Recipients: The Influence of I… (10.1155/2011/750836)
ORCID
34.51 23
35 Tricuspid Valve Regurgitation after Orthotopic Heart Transpl… (10.1155/2012/120702)
Abstract
34.51 23
36 Cyclosporine: A Commentary on Brand versus Generic Formulati… (10.1155/2011/480642)
ORCID
33.56 21
37 Current Status of Immunomodulatory and Cellular Therapies in… (10.1155/2011/637692)
ORCID
33.56 21
38 Increased Yield and Improved Transplantation Outcome of Mous… (10.1155/2012/856386)
ORCID
33.56 21
39 Hypothermic Machine Perfusion Preservation of the DCD Kidney… (10.1155/2013/802618)
ORCID
33.56 21
40 Donor-Recipient Size Mismatch in Paediatric Renal Transplant… (10.1155/2014/317574)
ORCID
33.56 21
41 Efficacy and Safety of Low-Dose Cyclosporine with Everolimus… (10.1155/2011/535983)
ORCID
32.53 19
42 Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitori… (10.1155/2012/563404)
ORCID
32.53 19
43 Pretransplant Fasting Glucose Predicts New-Onset Diabetes af… (10.1155/2012/614781)
ORCID
32.53 19
44 Risk-Adjusted Analysis of Relevant Outcome Drivers for Patie… (10.1155/2015/712049)
ORCID
31.97 18
45 Striated Muscle as Implantation Site for Transplanted Pancre… (10.1155/2011/352043)
ORCID
31.38 17
46 Treatment of Recurrent Focal Segmental Glomerulosclerosis in… (10.1155/2011/389542)
ORCID
31.38 17
47 The Natural History of Biopsy-Negative Rejection after Heart… (10.1155/2013/236720)
ORCID
31.38 17
48 Outcome and Challenges of Kidney Transplant in Patients with… (10.1155/2013/614610)
ORCID
31.38 17
49 Risk Factors Associated with Increased Morbidity in Living L… (10.1155/2015/949674)
ORCID
31.38 17
50 ABO Incompatible Kidney Transplantation—Current Status and U… (10.1155/2011/970421)
ORCID
30.76 16